Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 27;96:107615. doi: 10.1016/j.intimp.2021.107615

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Elsevier B.V. All rights reserved.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 2 — Associations between immune signatures and clinical features in COVID-19 patients. A. Associations between immune signature scores and HFD-45 values and ventilator-free days. The Spearman’s correlation test P-values and correlation coefficients are shown. B. Comparisons of immune signature scores between ICU and non-ICU patients and between MVS and non-MVS patients. The one-tailed Mann–Whitney U test P-values are shown. C. Associations between immune signature scores and age. D. Comparisons of immune signature scores between COVID-19 patients and the patients infected with other viruses. E. Comparisons of the scores of three immune-inhibiting signatures (type II IFN response, Treg, and neutrophils) between non-MVS and MVS patients. F. The scores of type II IFN response have negative correlations with HFD-45 values and ventilator-free days and are higher in ICU than in non-ICU patients.

Fig. 2 — Associations between immune signatures and clinical features in COVID-19 patients. A. Associations between immune signature scores and HFD-45 values and ventilator-free days. The Spearman’s correlation test P-values and correlation coefficients are shown. B. Comparisons of immune signature scores between ICU and non-ICU patients and between MVS and non-MVS patients. The one-tailed Mann–Whitney U test P-values are shown. C. Associations between immune signature scores and age. D. Comparisons of immune signature scores between COVID-19 patients and the patients infected with other viruses. E. Comparisons of the scores of three immune-inhibiting signatures (type II IFN response, Treg, and neutrophils) between non-MVS and MVS patients. F. The scores of type II IFN response have negative correlations with HFD-45 values and ventilator-free days and are higher in ICU than in non-ICU patients.